HCPCS Code Details - J9144

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J9144
Description

Long description:
Injection, daratumumab, 10 mg and hyaluronidase-fihj

Short description:
Daratumumab, hyaluronidase

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Jan 01, 2021 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1D - Chemotherapy
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2021
Date added Added Jan 01, 2021
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J9144

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
October 1, 2024 - December 31, 2024 10 MG 51.411 - - - - - -
Jul 1, 2024 - Sep 30, 2024 10 MG 50.996 - - - - - -
April 1, 2024 - June 30, 2024 10 MG 48.799 - - - - - -
January 1, 2024 - March 31, 2024 10 MG 49.051 - - - - - -
October 1, 2023 - December 31, 2023 10 MG 49.31 20% - - - - -

See also


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”